Patient | Ethnicity | HLA-DRB1 genotype | ACPA | Disease duration (years) | Treatment | C-reactive proteina (mg/l) | Representation |
---|---|---|---|---|---|---|---|
RA1 | Caucasian | 03,0401 | + | 6 | M, S | 8 | Figure 1 |
RA2 | Caucasian | 03, 0401 | + | < 1 | Nil | 3 | Figures 1 to 5 |
RA3 | Caucasian/Pacific Islander | 0403, 0405 | - | < 1 | M, S, H | 3 | Figure 1 |
RA4 | Caucasian | 0401, 0404 | + | < 1 | L | 11 | Figures 1 to 5 |
RA5 | Caucasian | 0404, 1302 | + | 1 | M, S, H | 2 | Figure 1 |
RA6 | Caucasian | 0401 13 | + | > 5 | M, H | 1 | Figures 1 to 5 |
RA7 | Asian | 0405 | - | 1 | M | 1 | Figures 1 to 5 |
RA8 | Caucasian | 0401, 0404 | + | > 5 | L, H, S | 22 | Figures 1 to 5 |
RA9 | Caucasian | 0103, 0101 | + | < 1 | Nil | 4 | Figures 1 to 5 |
RA10 | Caucasian | 01, 1302 | + | 5 | H | 10 | Figures 1 to 5 |
RA11 | Caucasian | 04, 0301 | - | 4 | M, S, H | 3 | Figures 1 to 5 |
RA12 | Caucasian | 0401 | + | 0 | Nil | 45 | Figures 1 to 5 |
RA13 | Caucasian | 0101, 1301 | - | > 5 | M | 20 | Figures 1 to 6 |
RA14 | Caucasian | 0408, 11 | + | > 5 | M, S, H | 4.6 | Figures 1 to 6 |
RA15 | Caucasian | 0401, 0408 | + | 0 | Nil | 1 | Figures 1 to 6 |
RA16 | Caucasian | 0101, 0408 | + | 0 | Nil | 6 | Figures 1 to 6 |
RA17 | Caucasian | 0401, 03 | + | > 5 | M, A | 33 | Figure 6 |
RA18 | Caucasian | 0401, 03 | + | 3 | M | 2 | Figures 1 to 5 |
RA19 | Caucasian | 0101, 0103 | + | 2 | M, S, H | 5.3 | Figures 1 to 5 |
RA20 | Caucasian | 0401, 1501 | + | 2 | - | 9.9 | Figures 1 to 5 |
RA21 | Caucasian | 0401, 0101 | + | > 5 | M, P | 2 | Figures 1 to 5 |
HC1 | Caucasian | 01 | - | Â | Â | Â | Figures 1 to 5 |
HC2 | Caucasian | 03, 04 | - | Â | Â | Â | Figures 1 to 5 |
HC3 | Caucasian | 0401, 0701 | - | Â | Â | Â | Figures 1 to 5 |
HC4 | Caucasian | 0101, 08 | - | Â | Â | Â | Figures 1 to 5 |
HC5 | Caucasian | 1301, 0401 | - | Â | Â | Â | Figures 1 to 6 |
HC6 | Caucasian | 0401, 1301 | - | Â | Â | Â | Figures 1 to 6 |